accession stringclasses 716
values | cik stringclasses 420
values | company stringclasses 422
values | ticker stringclasses 394
values | filed_date stringdate 2026-07-21 00:00:00 2026-10-19 00:00:00 ⌀ | form stringclasses 1
value | signal stringclasses 12
values | negative bool 2
classes | file_name stringclasses 691
values | url stringlengths 44 98 |
|---|---|---|---|---|---|---|---|---|---|
0001104659-26-107275 | 1813814 | Definium Therapeutics, Inc. | DFTX | 2026-09-14 | 8-K | interim | false | tm2625365d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1813814/000110465926107275/tm2625365d1_ex99-2.htm |
0001104659-26-107275 | 1813814 | Definium Therapeutics, Inc. | DFTX | 2026-09-14 | 8-K | breakthrough | false | tm2625365d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1813814/000110465926107275/tm2625365d1_ex99-1.htm |
0001193125-26-389844 | 1789972 | Cullinan Therapeutics, Inc. | CGEM | 2026-09-14 | 8-K | endpoint_met | false | cgem-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1789972/000119312526389844/cgem-ex99_1.htm |
0001193125-26-389844 | 1789972 | Cullinan Therapeutics, Inc. | CGEM | 2026-09-14 | 8-K | interim | false | cgem-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1789972/000119312526389844/cgem-ex99_1.htm |
0001193125-26-389829 | 1595097 | Corbus Pharmaceuticals Holdings, Inc. | CRBP | 2026-09-14 | 8-K | topline | false | crbp-20260914.htm | https://www.sec.gov/Archives/edgar/data/1595097/000119312526389829/crbp-20260914.htm |
0001193125-26-389829 | 1595097 | Corbus Pharmaceuticals Holdings, Inc. | CRBP | 2026-09-14 | 8-K | interim | false | crbp-ex99_2.htm | https://www.sec.gov/Archives/edgar/data/1595097/000119312526389829/crbp-ex99_2.htm |
0001193125-26-389829 | 1595097 | Corbus Pharmaceuticals Holdings, Inc. | CRBP | 2026-09-14 | 8-K | fast_track | false | crbp-ex99_2.htm | https://www.sec.gov/Archives/edgar/data/1595097/000119312526389829/crbp-ex99_2.htm |
0001193125-26-390539 | 1808898 | Benitec Biopharma Inc. | BNTC | 2026-09-14 | 8-K | orphan | false | bntc-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1808898/000119312526390539/bntc-ex99_1.htm |
0001520138-26-000391 | 1580149 | BIOVIE INC. | null | 2026-09-14 | 8-K | clinical_hold | true | bivi-20260911_8kex1z1.htm | https://www.sec.gov/Archives/edgar/data/1580149/000152013826000391/bivi-20260911_8kex1z1.htm |
0001520138-26-000391 | 1580149 | BIOVIE INC. | null | 2026-09-14 | 8-K | ind | false | bivi-20260911_8kex1z1.htm | https://www.sec.gov/Archives/edgar/data/1580149/000152013826000391/bivi-20260911_8kex1z1.htm |
0001104659-26-107253 | 921114 | Armata Pharmaceuticals, Inc. | ARMP | 2026-09-14 | 8-K | breakthrough | false | tm2625289d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/921114/000110465926107253/tm2625289d1_ex99-1.htm |
0001104659-26-107253 | 921114 | Armata Pharmaceuticals, Inc. | ARMP | 2026-09-14 | 8-K | fast_track | false | tm2625289d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/921114/000110465926107253/tm2625289d1_ex99-1.htm |
0001213900-26-099702 | 1946563 | 60 DEGREES PHARMACEUTICALS, INC. | null | 2026-09-14 | 8-K | interim | false | ea0305442-8k_60degree.htm | https://www.sec.gov/Archives/edgar/data/1946563/000121390026099702/ea0305442-8k_60degree.htm |
0001140361-26-036277 | 1228627 | Opus Genetics, Inc. | IRD | 2026-09-11 | 8-K | topline | false | ef20081922_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1228627/000114036126036277/ef20081922_ex99-1.htm |
0001140361-26-036277 | 1228627 | Opus Genetics, Inc. | IRD | 2026-09-11 | 8-K | pdufa | false | ef20081922_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1228627/000114036126036277/ef20081922_ex99-1.htm |
0001193125-26-389318 | 1755237 | Korsana Biosciences, Inc. | CYCN | 2026-09-11 | 8-K | ind | false | d178159d8k.htm | https://www.sec.gov/Archives/edgar/data/1755237/000119312526389318/d178159d8k.htm |
0001193125-26-389400 | 1070494 | ACADIA PHARMACEUTICALS INC | ACAD | 2026-09-11 | 8-K | endpoint_met | false | d143428dex991.htm | https://www.sec.gov/Archives/edgar/data/1070494/000119312526389400/d143428dex991.htm |
0001193125-26-389400 | 1070494 | ACADIA PHARMACEUTICALS INC | ACAD | 2026-09-11 | 8-K | crl | true | d143428dex991.htm | https://www.sec.gov/Archives/edgar/data/1070494/000119312526389400/d143428dex991.htm |
0001104659-26-106699 | 1566044 | Yarrow Bioscience, Inc. | YARW | 2026-09-10 | 8-K | topline | false | tm2624937d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1566044/000110465926106699/tm2624937d1_ex99-1.htm |
0001104659-26-106699 | 1566044 | Yarrow Bioscience, Inc. | YARW | 2026-09-10 | 8-K | crl | true | tm2624937d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1566044/000110465926106699/tm2624937d1_ex99-2.htm |
0001104659-26-106699 | 1566044 | Yarrow Bioscience, Inc. | YARW | 2026-09-10 | 8-K | clinical_hold | true | tm2624937d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1566044/000110465926106699/tm2624937d1_ex99-2.htm |
0001104659-26-106699 | 1566044 | Yarrow Bioscience, Inc. | YARW | 2026-09-10 | 8-K | fast_track | false | tm2624937d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1566044/000110465926106699/tm2624937d1_ex99-2.htm |
0001104659-26-106699 | 1566044 | Yarrow Bioscience, Inc. | YARW | 2026-09-10 | 8-K | orphan | false | tm2624937d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1566044/000110465926106699/tm2624937d1_ex99-2.htm |
0001104659-26-106699 | 1566044 | Yarrow Bioscience, Inc. | YARW | 2026-09-10 | 8-K | ind | false | tm2624937d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1566044/000110465926106699/tm2624937d1_ex99-2.htm |
0001819790-26-000066 | 1819790 | Tarsus Pharmaceuticals, Inc. | TARS | 2026-09-10 | 8-K | topline | false | exhibit991-tarsuspharmac.htm | https://www.sec.gov/Archives/edgar/data/1819790/000181979026000066/exhibit991-tarsuspharmac.htm |
0001819790-26-000066 | 1819790 | Tarsus Pharmaceuticals, Inc. | TARS | 2026-09-10 | 8-K | clinical_hold | true | apollo-mergeragreementag.htm | https://www.sec.gov/Archives/edgar/data/1819790/000181979026000066/apollo-mergeragreementag.htm |
0001819790-26-000066 | 1819790 | Tarsus Pharmaceuticals, Inc. | TARS | 2026-09-10 | 8-K | ind | false | apollo-mergeragreementag.htm | https://www.sec.gov/Archives/edgar/data/1819790/000181979026000066/apollo-mergeragreementag.htm |
0001178253-26-000031 | 1178253 | SCYNEXIS INC | SCYX | 2026-09-10 | 8-K | orphan | false | scyx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1178253/000117825326000031/scyx-ex99_1.htm |
0001193125-26-387232 | 1678660 | Prelude Therapeutics Inc | PRLD | 2026-09-10 | 8-K | ind | false | prld-20260910.htm | https://www.sec.gov/Archives/edgar/data/1678660/000119312526387232/prld-20260910.htm |
0001493152-26-042021 | 1624326 | PAVmed Inc. | PAVM | 2026-09-10 | 8-K | clinical_hold | true | ex1-1.htm | https://www.sec.gov/Archives/edgar/data/1624326/000149315226042021/ex1-1.htm |
0001129928-26-000055 | 1129928 | ONCOLYTICS BIOTECH INC | ONCY | 2026-09-10 | 8-K | fast_track | false | oncolyticsrascrcpreclinica.htm | https://www.sec.gov/Archives/edgar/data/1129928/000112992826000055/oncolyticsrascrcpreclinica.htm |
0001829126-26-009977 | 1979414 | NEONC TECHNOLOGIES HOLDINGS, INC. | NTHI | 2026-09-10 | 8-K | clinical_hold | true | neonctechnologies_ex10-2.htm | https://www.sec.gov/Archives/edgar/data/1979414/000182912626009977/neonctechnologies_ex10-2.htm |
0001193125-26-387197 | 1314102 | EyePoint, Inc. | EYPT | 2026-09-10 | 8-K | topline | false | eypt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1314102/000119312526387197/eypt-ex99_1.htm |
0001437749-26-030073 | 1053691 | CervoMed Inc. | CRVO | 2026-09-10 | 8-K | orphan | false | ex_1014623.htm | https://www.sec.gov/Archives/edgar/data/1053691/000143774926030073/ex_1014623.htm |
0001193125-26-387310 | 1841387 | Candel Therapeutics, Inc. | CADL | 2026-09-10 | 8-K | fast_track | false | cadl-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1841387/000119312526387310/cadl-ex99_1.htm |
0001193125-26-387310 | 1841387 | Candel Therapeutics, Inc. | CADL | 2026-09-10 | 8-K | orphan | false | cadl-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1841387/000119312526387310/cadl-ex99_1.htm |
0001193125-26-387267 | 1095981 | CERENOME, INC. | CNSY | 2026-09-10 | 8-K | clinical_hold | true | d382364dex101.htm | https://www.sec.gov/Archives/edgar/data/1095981/000119312526387267/d382364dex101.htm |
0001935979-26-000077 | 1935979 | Biohaven Ltd. | BHVN | 2026-09-10 | 8-K | topline | false | bhvn-20260904.htm | https://www.sec.gov/Archives/edgar/data/1935979/000193597926000077/bhvn-20260904.htm |
0001935979-26-000077 | 1935979 | Biohaven Ltd. | BHVN | 2026-09-10 | 8-K | clinical_hold | true | bhvn-20260904.htm | https://www.sec.gov/Archives/edgar/data/1935979/000193597926000077/bhvn-20260904.htm |
0001628280-26-061208 | 805928 | Axogen, Inc. | AXGN | 2026-09-10 | 8-K | clinical_hold | true | exhibit11-8xk09102026.htm | https://www.sec.gov/Archives/edgar/data/805928/000162828026061208/exhibit11-8xk09102026.htm |
0001628280-26-061393 | 805928 | Axogen, Inc. | AXGN | 2026-09-10 | 8-K | clinical_hold | true | exhibit21-8xka.htm | https://www.sec.gov/Archives/edgar/data/805928/000162828026061393/exhibit21-8xka.htm |
0001628280-26-061208 | 805928 | Axogen, Inc. | AXGN | 2026-09-10 | 8-K | ind | false | exhibit11-8xk09102026.htm | https://www.sec.gov/Archives/edgar/data/805928/000162828026061208/exhibit11-8xk09102026.htm |
0001867096-26-000077 | 1867096 | Xeris Biopharma Holdings, Inc. | XERS | 2026-09-09 | 8-K | topline | false | exh992xp-8121event.htm | https://www.sec.gov/Archives/edgar/data/1867096/000186709626000077/exh992xp-8121event.htm |
0001501697-26-000076 | 1501697 | X4 Pharmaceuticals, Inc | XFOR | 2026-09-09 | 8-K | topline | false | x4pharmaceuticalscorpora.htm | https://www.sec.gov/Archives/edgar/data/1501697/000150169726000076/x4pharmaceuticalscorpora.htm |
0001193125-26-385910 | 34956 | TENAX THERAPEUTICS, INC. | TENX | 2026-09-09 | 8-K | topline | false | d43255dex991.htm | https://www.sec.gov/Archives/edgar/data/34956/000119312526385910/d43255dex991.htm |
0001193125-26-385910 | 34956 | TENAX THERAPEUTICS, INC. | TENX | 2026-09-09 | 8-K | endpoint_missed | true | d43255dex991.htm | https://www.sec.gov/Archives/edgar/data/34956/000119312526385910/d43255dex991.htm |
0001708599-26-000054 | 1708599 | Serina Therapeutics, Inc. | SER | 2026-09-09 | 8-K | topline | false | cohort1pr09032026_sredits.htm | https://www.sec.gov/Archives/edgar/data/1708599/000170859926000054/cohort1pr09032026_sredits.htm |
0001193125-26-385901 | 1782223 | Pyxis Oncology, Inc. | PYXS | 2026-09-09 | 8-K | fast_track | false | pyxs-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1782223/000119312526385901/pyxs-ex99_1.htm |
0001140361-26-035979 | 1228627 | Opus Genetics, Inc. | IRD | 2026-09-09 | 8-K | topline | false | ef20081753_8k.htm | https://www.sec.gov/Archives/edgar/data/1228627/000114036126035979/ef20081753_8k.htm |
0001140361-26-035979 | 1228627 | Opus Genetics, Inc. | IRD | 2026-09-09 | 8-K | pdufa | false | ef20081753_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1228627/000114036126035979/ef20081753_ex99-2.htm |
0001104659-26-106156 | 1638287 | MetaVia Inc. | MTVA | 2026-09-09 | 8-K | topline | false | mtva-20260909xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1638287/000110465926106156/mtva-20260909xex99d1.htm |
0001213900-26-098213 | 1873875 | Incannex Healthcare Inc. | IXHL | 2026-09-09 | 8-K | topline | false | ea030478201ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1873875/000121390026098213/ea030478201ex99-1.htm |
0001213900-26-098213 | 1873875 | Incannex Healthcare Inc. | IXHL | 2026-09-09 | 8-K | fast_track | false | ea030478201ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1873875/000121390026098213/ea030478201ex99-1.htm |
0001213900-26-098213 | 1873875 | Incannex Healthcare Inc. | IXHL | 2026-09-09 | 8-K | ind | false | ea030478201ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1873875/000121390026098213/ea030478201ex99-1.htm |
0001193125-26-385430 | 2044725 | Evommune, Inc. | EVMN | 2026-09-09 | 8-K | topline | false | evmn-20260908.htm | https://www.sec.gov/Archives/edgar/data/2044725/000119312526385430/evmn-20260908.htm |
0001193125-26-385430 | 2044725 | Evommune, Inc. | EVMN | 2026-09-09 | 8-K | endpoint_missed | true | evmn-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2044725/000119312526385430/evmn-ex99_1.htm |
0001193125-26-386561 | 1841387 | Candel Therapeutics, Inc. | CADL | 2026-09-09 | 8-K | fast_track | false | d738484dex991.htm | https://www.sec.gov/Archives/edgar/data/1841387/000119312526386561/d738484dex991.htm |
0001193125-26-386561 | 1841387 | Candel Therapeutics, Inc. | CADL | 2026-09-09 | 8-K | orphan | false | d738484dex991.htm | https://www.sec.gov/Archives/edgar/data/1841387/000119312526386561/d738484dex991.htm |
0001501697-26-000072 | 1501697 | X4 Pharmaceuticals, Inc | XFOR | 2026-09-08 | 8-K | topline | false | a991_x4typecoutcome.htm | https://www.sec.gov/Archives/edgar/data/1501697/000150169726000072/a991_x4typecoutcome.htm |
0001501697-26-000072 | 1501697 | X4 Pharmaceuticals, Inc | XFOR | 2026-09-08 | 8-K | fast_track | false | a991_x4typecoutcome.htm | https://www.sec.gov/Archives/edgar/data/1501697/000150169726000072/a991_x4typecoutcome.htm |
0001193125-26-384430 | 863894 | VERU INC. | VERU | 2026-09-08 | 8-K | topline | false | d543118dex991.htm | https://www.sec.gov/Archives/edgar/data/863894/000119312526384430/d543118dex991.htm |
0001193125-26-384430 | 863894 | VERU INC. | VERU | 2026-09-08 | 8-K | interim | false | d543118dex991.htm | https://www.sec.gov/Archives/edgar/data/863894/000119312526384430/d543118dex991.htm |
0001104659-26-105688 | 1888886 | Structure Therapeutics Inc. | GPCR | 2026-09-08 | 8-K | topline | false | tm2624945d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1888886/000110465926105688/tm2624945d1_ex99-1.htm |
0001636282-26-000113 | 1636282 | Spyre Therapeutics, Inc. | SYRE | 2026-09-08 | 8-K | topline | false | syre-20260908.htm | https://www.sec.gov/Archives/edgar/data/1636282/000163628226000113/syre-20260908.htm |
0001636282-26-000113 | 1636282 | Spyre Therapeutics, Inc. | SYRE | 2026-09-08 | 8-K | endpoint_met | false | spyre-spyre003releasexexx9.htm | https://www.sec.gov/Archives/edgar/data/1636282/000163628226000113/spyre-spyre003releasexexx9.htm |
0001140361-26-035859 | 1635088 | Roivant Sciences Ltd. | ROIV | 2026-09-08 | 8-K | topline | false | ef20081686_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1635088/000114036126035859/ef20081686_ex99-1.htm |
0001140361-26-035859 | 1635088 | Roivant Sciences Ltd. | ROIV | 2026-09-08 | 8-K | endpoint_met | false | ef20081686_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1635088/000114036126035859/ef20081686_ex99-1.htm |
0001193125-26-384386 | 1782223 | Pyxis Oncology, Inc. | PYXS | 2026-09-08 | 8-K | fast_track | false | pyxs-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1782223/000119312526384386/pyxs-ex99_1.htm |
0001140361-26-035853 | 1472091 | PDS Biotechnology Corp | PDSB | 2026-09-08 | 8-K | ind | false | ef20081705_8k.htm | https://www.sec.gov/Archives/edgar/data/1472091/000114036126035853/ef20081705_8k.htm |
0001104659-26-105733 | 1814114 | Orchestra BioMed Holdings, Inc. | OBIO | 2026-09-08 | 8-K | topline | false | tm2624943d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1814114/000110465926105733/tm2624943d1_ex99-1.htm |
0001104659-26-105968 | 1372299 | Ocugen, Inc. | OCGN | 2026-09-08 | 8-K | topline | false | tm2624985d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1372299/000110465926105968/tm2624985d1_ex99-1.htm |
0001104659-26-105968 | 1372299 | Ocugen, Inc. | OCGN | 2026-09-08 | 8-K | interim | false | tm2624985d1_8k.htm | https://www.sec.gov/Archives/edgar/data/1372299/000110465926105968/tm2624985d1_8k.htm |
0001104659-26-105968 | 1372299 | Ocugen, Inc. | OCGN | 2026-09-08 | 8-K | orphan | false | tm2624985d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1372299/000110465926105968/tm2624985d1_ex99-1.htm |
0001193125-26-385194 | 1652130 | Intellia Therapeutics, Inc. | NTLA | 2026-09-08 | 8-K | orphan | false | ntla-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1652130/000119312526385194/ntla-ex99_1.htm |
0001193125-26-385194 | 1652130 | Intellia Therapeutics, Inc. | NTLA | 2026-09-08 | 8-K | pdufa | false | ntla-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1652130/000119312526385194/ntla-ex99_1.htm |
0002007919-26-000047 | 2007919 | Inhibrx Biosciences, Inc. | INBX | 2026-09-08 | 8-K | topline | false | inhibrx-20260908.htm | https://www.sec.gov/Archives/edgar/data/2007919/000200791926000047/inhibrx-20260908.htm |
0002007919-26-000047 | 2007919 | Inhibrx Biosciences, Inc. | INBX | 2026-09-08 | 8-K | breakthrough | false | inbrx-106investorovervie.htm | https://www.sec.gov/Archives/edgar/data/2007919/000200791926000047/inbrx-106investorovervie.htm |
0001193125-26-385293 | 1750149 | Inhibikase Therapeutics, Inc. | IKT | 2026-09-08 | 8-K | topline | false | d152999dex991.htm | https://www.sec.gov/Archives/edgar/data/1750149/000119312526385293/d152999dex991.htm |
0001193125-26-385293 | 1750149 | Inhibikase Therapeutics, Inc. | IKT | 2026-09-08 | 8-K | interim | false | d152999dex991.htm | https://www.sec.gov/Archives/edgar/data/1750149/000119312526385293/d152999dex991.htm |
0001193125-26-385293 | 1750149 | Inhibikase Therapeutics, Inc. | IKT | 2026-09-08 | 8-K | orphan | false | d152999dex991.htm | https://www.sec.gov/Archives/edgar/data/1750149/000119312526385293/d152999dex991.htm |
0001824293-26-000057 | 1824293 | GRI Bio, Inc. | GRI | 2026-09-08 | 8-K | interim | false | gribio_deckx082526.htm | https://www.sec.gov/Archives/edgar/data/1824293/000182429326000057/gribio_deckx082526.htm |
0001824293-26-000057 | 1824293 | GRI Bio, Inc. | GRI | 2026-09-08 | 8-K | orphan | false | gribio_deckx082526.htm | https://www.sec.gov/Archives/edgar/data/1824293/000182429326000057/gribio_deckx082526.htm |
0001193125-26-384403 | 1813814 | Definium Therapeutics, Inc. | DFTX | 2026-09-08 | 8-K | breakthrough | false | dftx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1813814/000119312526384403/dftx-ex99_1.htm |
0001628280-26-060904 | 2131524 | Braveheart Bio, Inc. | BRVE | 2026-09-08 | 8-K | interim | false | brve-q2268xkex991xearnings.htm | https://www.sec.gov/Archives/edgar/data/2131524/000162828026060904/brve-q2268xkex991xearnings.htm |
0001628280-26-060904 | 2131524 | Braveheart Bio, Inc. | BRVE | 2026-09-08 | 8-K | ind | false | brve-q2268xkex991xearnings.htm | https://www.sec.gov/Archives/edgar/data/2131524/000162828026060904/brve-q2268xkex991xearnings.htm |
0001493152-26-041706 | 1701478 | Azitra, Inc. | AZTR | 2026-09-08 | 8-K | topline | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1701478/000149315226041706/ex99-1.htm |
0001493152-26-041706 | 1701478 | Azitra, Inc. | AZTR | 2026-09-08 | 8-K | fast_track | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1701478/000149315226041706/ex99-1.htm |
0001193125-26-385355 | 1745648 | Apnimed, Inc. | APMD | 2026-09-08 | 8-K | pdufa | false | apmd-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1745648/000119312526385355/apmd-ex99_1.htm |
0001720580-26-000056 | 1720580 | Adicet Bio, Inc. | ACET | 2026-09-08 | 8-K | ind | false | acet-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1720580/000172058026000056/acet-ex99_1.htm |
0001213900-26-098056 | 1946563 | 60 DEGREES PHARMACEUTICALS, INC. | null | 2026-09-08 | 8-K | interim | false | ea030486201ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1946563/000121390026098056/ea030486201ex99-1.htm |
0001213900-26-098056 | 1946563 | 60 DEGREES PHARMACEUTICALS, INC. | null | 2026-09-08 | 8-K | pdufa | false | ea030486201ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1946563/000121390026098056/ea030486201ex99-1.htm |
0001193125-26-383645 | 1652130 | Intellia Therapeutics, Inc. | NTLA | 2026-09-04 | 8-K | orphan | false | d110798dex991.htm | https://www.sec.gov/Archives/edgar/data/1652130/000119312526383645/d110798dex991.htm |
0001140361-26-035802 | 874015 | IONIS PHARMACEUTICALS INC | IONS | 2026-09-04 | 8-K | topline | false | ef20081690_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/874015/000114036126035802/ef20081690_ex99-1.htm |
0001140361-26-035657 | 874015 | IONIS PHARMACEUTICALS INC | IONS | 2026-09-04 | 8-K | endpoint_met | false | ef20081649_8k.htm | https://www.sec.gov/Archives/edgar/data/874015/000114036126035657/ef20081649_8k.htm |
0001140361-26-035802 | 874015 | IONIS PHARMACEUTICALS INC | IONS | 2026-09-04 | 8-K | endpoint_missed | true | ef20081690_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/874015/000114036126035802/ef20081690_ex99-1.htm |
0001649094-26-000045 | 1649094 | Vaxcyte, Inc. | PCVX | 2026-09-03 | 8-K | topline | false | a20260831-8xkxpressrelea.htm | https://www.sec.gov/Archives/edgar/data/1649094/000164909426000045/a20260831-8xkxpressrelea.htm |
0001193125-26-381899 | 818686 | TEVA PHARMACEUTICAL INDUSTRIES LTD | null | 2026-09-03 | 8-K | fast_track | false | d153033dex991.htm | https://www.sec.gov/Archives/edgar/data/818686/000119312526381899/d153033dex991.htm |
0001599298-26-000076 | 1599298 | Summit Therapeutics Inc. | SMMT | 2026-09-03 | 8-K | pdufa | false | a2026_prx0902xharmoni-2o.htm | https://www.sec.gov/Archives/edgar/data/1599298/000159929826000076/a2026_prx0902xharmoni-2o.htm |
0001140361-26-035515 | 1787297 | Passage BIO, Inc. | PASG | 2026-09-03 | 8-K | clinical_hold | true | ef20081513_ex2-1.htm | https://www.sec.gov/Archives/edgar/data/1787297/000114036126035515/ef20081513_ex2-1.htm |
0001104659-26-105052 | 1408443 | Milestone Pharmaceuticals Inc. | MIST | 2026-09-03 | 8-K | endpoint_met | false | tm2624766d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1408443/000110465926105052/tm2624766d1_ex99-1.htm |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.